Crinetics Pharmaceuticals Inc
(CRNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 2,679 | 709 | 458 | 439 | 3,131 |
| Gross Profit | 2,679 | 709 | 458 | 439 | 3,131 |
| Operating Expenses | 50,657 | 48,265 | 43,912 | 43,484 | 36,958 |
| Operating Income | -47,978 | -47,556 | -43,454 | -43,045 | -33,827 |
| Other Income | 1,983 | 2,565 | 1,529 | 670 | -800 |
| Pre-tax Income | -45,995 | -44,991 | -41,925 | -42,375 | -34,627 |
| Net Income Continuous | -45,995 | -44,991 | -41,925 | -42,375 | -34,627 |
| Net Income | $-45,995 | $-44,991 | $-41,925 | $-42,375 | $-34,627 |
| EPS Basic Total Ops | -0.85 | -0.83 | -0.78 | -0.81 | -0.73 |
| EPS Basic Continuous Ops | -0.85 | -0.84 | -0.78 | -0.81 | -0.73 |
| EPS Diluted Total Ops | -0.85 | -0.83 | -0.78 | -0.81 | -0.73 |
| EPS Diluted Continuous Ops | -0.85 | -0.84 | -0.78 | -0.81 | -0.73 |
| EBITDA(a) | $-48,225 | $-47,627 | $-43,338 | $-42,635 | $-33,265 |